Browse the evidence

In morbidly obese individuals, elevated tonic glucose metabolism in the dorsal caudate nucleus mediates abnormal anticipatory reward processing, characterized by heightened connectivity with the amygdala and insula and a failure to activate dorsolateral prefrontal inhibitory control when viewing appetizing food cues.

If you struggle with obesity, your brain may be biologically wired to react more strongly to food cues than others. This isn't a moral failing; it's a neurobiological reality where the 'reward' center (caudate) is overactive and the 'control' center (prefrontal cortex) is underactive. Recognizing this helps shift the strategy from 'trying harder' to 'managing cues' (e.g., removing visual food triggers) to bypass the hyperactive reward pathway.

Dietary medium-chain triglycerides (MCT) are ineffective for long-term body weight control because achieving weight loss requires an energy intake level (approx. 50% of calories from MCT) that is unsustainable for long-term compliance.

Do not rely on MCT oil for weight loss. While MCTs are metabolized differently than long-chain fats, the amount needed to actually cause weight loss is so high (around 50% of your daily calories) that it causes gastrointestinal distress and is impossible to maintain. Focus on sustainable caloric deficits using a balanced diet rather than seeking 'metabolic shortcuts' with specialized oils.

Metabolic syndrome is associated with a systemic proinflammatory state and increased oxidative stress, characterized by elevated plasma levels of TNFα and IL-6, higher malondialdehyde (lipid peroxidation), and lower plasma superoxide dismutase (SOD) activity.

If you have metabolic syndrome, your body is in a state of chronic low-grade inflammation and oxidative stress. This isn't just 'bad luck'; it's a biological response to visceral fat and metabolic dysfunction. Recognizing this inflammatory state is the first step to understanding why managing weight, blood sugar, and blood pressure is critical for long-term health.

Patients with Metabolic Syndrome exhibit higher antioxidant enzyme activities (Catalase, Glutathione Reductase) and protein levels in Peripheral Blood Mononuclear Cells (PBMCs) compared to those without MetS, likely due to a pre-activated state of immune cells.

Your immune cells are working overtime to fight the oxidative stress caused by metabolic syndrome. This is why your body might have higher levels of certain protective enzymes in your white blood cells. It's a sign of your body trying to protect itself, but it also indicates that your immune system is chronically activated, which is a risk factor for long-term health issues.

Leptin and insulin act as redundant but complementary adiposity signals to the central nervous system (CNS), specifically the ventral hypothalamus, to regulate long-term body fat stores by modulating neuropeptide expression (NPY/AgRP and POMC/CART).

Your body uses hormones like leptin and insulin to defend a specific body fat level. When you lose weight, these signals drop, triggering hunger and reducing energy expenditure to regain the lost fat. Sustainable weight management requires understanding that this is a biological defense mechanism, not just a lack of willpower.

CNS insulin action is dependent on intact leptin signaling, and leptin's effects on energy expenditure are mediated through melanocortin receptors (specifically MC4R).

Treating obesity often requires addressing the brain's downstream response (melanocortin system), not just the upstream hormones. If your body is resistant to leptin or insulin, targeting the final common pathway (like MC4R) might be more effective.

Weight loss therapies, including bariatric surgery and hypocaloric diets, inevitably lead to skeletal muscle catabolism, particularly during rapid weight loss phases.

When you start a diet or surgery, expect some muscle loss. To protect your muscle, ensure you eat enough protein and engage in resistance training, as rapid weight loss makes muscle loss more likely.

High-fat diets increase serum lipopolysaccharide (LPS) levels (metabolic endotoxemia) by increasing chylomicron transport, decreasing gut barrier integrity, and reducing alkaline phosphatase activity, leading to systemic low-grade inflammation.

High-fat diets can compromise your gut barrier, allowing bacterial toxins (LPS) to enter your bloodstream. This triggers inflammation, which is linked to obesity and metabolic syndrome. To mitigate this, focus on diets that support gut barrier integrity, such as those rich in prebiotics, which have been shown to improve gut barrier function and reduce endotoxemia.

SGLT2 inhibition (canagliflozin) reduces adiposity and activates lipolysis exclusively through FGF21-dependent mechanisms, while its effects on lipid oxidation, ketogenesis, and hepatic steatosis reduction are FGF21-independent.

SGLT2 inhibitors reduce body fat by triggering a hormonal signal (FGF21) that activates fat burning (lipolysis). This process is distinct from simple calorie restriction and requires the presence of FGF21 to effectively reduce fat mass.

SGLT2 inhibition induces a fasting-like metabolic state characterized by increased fatty acid oxidation, ketogenesis, and reduced hepatic steatosis independently of FGF21.

SGLT2 inhibitors shift the body's fuel source to fat and ketones, mimicking a fasting state. This metabolic switch occurs even if the hormonal pathway for fat loss (FGF21) is blocked.

HIV protease inhibitor (PI) therapy causes lipodystrophy in HIV-infected patients, characterized by peripheral fat loss and truncal fat accumulation, along with metabolic abnormalities including insulin resistance and dyslipidemia.

If you are taking HIV protease inhibitors, be aware that you may experience changes in body fat distribution (loss in face/limbs, gain in abdomen/neck) and metabolic issues like insulin resistance. Regular monitoring of lipids and glucose is recommended. Do not stop your medication due to these changes without consulting your doctor, as the benefits of HIV suppression usually outweigh the side effects.

Level 3 portable sleep tests demonstrate high diagnostic accuracy (AUC 0.85–0.99) for moderate to severe obstructive sleep apnea in adults with high pretest probability and no unstable comorbidities, yielding clinical management outcomes equivalent to Level 1 polysomnography.

If you suspect you have moderate to severe sleep apnea (loud snoring, witnessed breathing pauses, daytime sleepiness) and have stable health, a home sleep test is a valid, accurate, and convenient alternative to an overnight lab study. It provides the necessary data to start treatment (like CPAP) with outcomes equivalent to the more expensive and time-consuming lab test. However, if you have other complex sleep disorders or unstable heart/lung conditions, you still need the comprehensive lab test.

Obese individuals exhibit altered glutamine metabolism, characterized by decreased serum glutamine and alpha-ketoglutarate, and increased succinate, which correlates with M1 macrophage accumulation.

Obesity is associated with lower levels of glutamine and alpha-ketoglutarate, and higher succinate. While this is a marker of disease, simply taking glutamine supplements may not fully reverse these changes in humans, as muscle mass and other factors also play a role. Focus on overall metabolic health.

Pro-inflammatory cytokines IL-1beta and TNF-alpha are somnogenic; their expression increases with waking activity and sleep deprivation, and they promote non-rapid-eye movement (NREM) sleep and slow-wave activity (SWA).

Prioritize sleep hygiene not just for rest, but to regulate inflammation. Chronic wakefulness or poor sleep increases pro-inflammatory cytokines like IL-1beta and TNF-alpha, which can disrupt sleep architecture and overall health. Managing inflammation through lifestyle may improve sleep, and good sleep helps manage inflammation.

The NLRP3 inflammasome is a critical mediator of sleep regulation; its activation leads to the production of IL-1beta and IL-18, which promote NREM sleep and slow-wave activity.

Understanding that sleep loss activates the NLRP3 inflammasome suggests that chronic sleep deprivation may fuel a cycle of inflammation. Breaking this cycle by improving sleep may reduce inflammasome activity.

Circadian rhythm disruption is associated with increased morbidity risk for inflammatory diseases, including cardiovascular disease, cancer, and metabolic disease.

Maintaining a regular sleep-wake cycle is crucial for long-term health, as disrupting your circadian rhythm increases the risk of inflammatory diseases like heart disease and cancer.

Isocaloric substitution of added sugars (sucrose or HFCS) for other carbohydrates does not increase risk factors for obesity, type 2 diabetes, or cardiovascular disease in adults.

If you consume added sugars within your daily calorie needs, replacing them with other carbohydrates (like starch) will not improve your metabolic health markers (weight, blood sugar, lipids) any more than keeping them would. The key is total energy balance, not the specific source of calories, unless you are consuming excessive amounts that lead to a caloric surplus.

In morbidly obese humans, insulin resistance is associated with significantly lower AMPK activity and higher oxidative stress (protein carbonylation) in adipose tissue compared to insulin-sensitive obesity, regardless of fat depot.

For morbidly obese individuals, achieving weight loss is a step, but metabolic health (insulin sensitivity) is distinct. Research suggests that insulin-resistant obesity involves lower AMPK activity and higher oxidative stress in fat tissue. While this paper is observational, it highlights that metabolic health is not just about weight but about how fat tissue functions at a molecular level. Interventions that improve AMPK activity (like exercise) may be crucial for improving insulin sensitivity beyond just weight loss.

Gene expression changes in adipose tissue of insulin-resistant obese individuals are depot-specific, whereas AMPK activity and oxidative stress are uniform across depots.

Fat tissue is not uniform. In insulin-resistant obesity, some molecular markers (like oxidative stress) are high everywhere, but the genes being turned on or off depend on where the fat is stored (e.g., belly vs. under skin). This complexity means treatments might need to target specific fat depots or understand that 'fat' is not a single organ with a single behavior.

Lipoprotein lipase (LPL) is not strictly necessary or sufficient for normal fat deposition in white adipose tissue; downstream regulation of fatty acid uptake and esterification (mediated by insulin and acylation-stimulating protein) is the primary determinant of fat storage.

Do not assume that strategies targeting Lipoprotein Lipase (LPL) activity alone will effectively change body fat levels. Fat storage in adipose tissue is primarily controlled by what happens *after* LPL releases fatty acids—specifically, how insulin and other factors drive those fatty acids back into fat cells (esterification). If you increase LPL activity without ensuring these downstream storage pathways are active, you may simply circulate more fatty acids rather than storing them.

Hyperinsulinemia in obese PCOS women is primarily driven by reduced hepatic insulin extraction and skeletal muscle insulin resistance, rather than solely by increased pancreatic insulin secretion.

High insulin levels in PCOS are not just because your pancreas is working too hard; your liver is also clearing insulin less efficiently, and your muscles are resisting its effects. This combination leads to high circulating insulin, which can further drive androgen production and weight gain.

Obesity in postmenopausal women increases breast cancer risk and recurrence through hormonal mechanisms, specifically elevated estrone, estradiol, insulin, and IGF-1 levels, and reduced sex hormone-binding globulin (SHBG).

For postmenopausal women, excess body fat is not just a storage issue but a hormonal one. Fat tissue produces estrogen and affects insulin/IGF-1 levels, which can fuel breast cancer growth. Reducing body fat may help normalize these hormone levels, potentially lowering the risk of cancer progression.

Rapid urbanization and globalization in South Africa drive a nutritional transition characterized by increased consumption of high-fat, high-sugar processed foods and decreased physical activity, leading to a significant rise in obesity prevalence across all demographic groups.

To combat obesity in urbanizing environments, policy and individual actions must focus on modifying the food environment (limiting access to cheap, high-fat processed foods) and increasing opportunities for physical activity, rather than relying solely on individual willpower.

Ghrelin is the only known orexigenic gut hormone, and its levels are inversely correlated with body mass index, with obese subjects showing a less marked drop in plasma ghrelin after meal ingestion.

Ghrelin is the 'hunger hormone,' and its levels are lower in obese individuals. However, obese people have a blunted response to meals, meaning their ghrelin doesn't drop as much as it should, potentially contributing to overeating.